Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
11918001000001112 | Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
12052301000001111 | Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Is a | Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler | false | Inferred relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Availability | Available only as a proprietary | false | Additional relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | NHS prescribing status | NHS prescribable | false | Additional relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Legal category | Prescription Only Medicine | false | Additional relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Product name type | Generic name | false | Additional relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | CSM recommendation to report adverse reactions | Report only serious adverse reactions to the Committee on Safety of Medicines | false | Additional relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Has active ingredient | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Has active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Seretide 500 Accuhaler | Is a | False | Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler - product | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets